| Literature DB >> 29671257 |
Takamitsu Tanaka1, Masao Saotome2, Hideki Katoh1, Terumori Satoh1, Prottoy Hasan1, Hayato Ohtani1, Hiroshi Satoh1, Hideharu Hayashi1, Yuichiro Maekawa1.
Abstract
Accumulating evidence has revealed pivotal roles of glycogen synthase kinase-3β (GSK3β) inactivation on cardiac protection. Because the precise mechanisms of cardiac protection against ischemia/reperfusion (I/R) injury by GSK3β-inactivation remain elusive, we investigated the relationship between GSK3β-mediated mitochondrial hexokinase II (mitoHK-II; a downstream target of GSK3β) dissociation and mitochondrial permeability transition pore (mPTP) opening. In Langendorff-perfused hearts, GSK3β inactivation by SB216763 improved the left ventricular-developed pressure and retained mitoHK-II binding after I/R. In permeabilized myocytes, GSK3β depolarized mitochondrial membrane potential with accelerated mitochondrial calcein release (suggesting GSK3β-mediated mPTP opening) and decreased mitoHK-II bindings. GSK3β-mediated mPTP opening depended on mitoHK-II binding, i.e., it was accelerated by dissociation of mitoHK-II (dicyclohexylcarbodiimide) and attenuated by enhancement of mitoHK-II binding (dextran). However, inactivation of mitoHK-II by glucose-depletion or glucose-6-phosphate inhibited the GSK3β-mediated mPTP opening. We conclude that GSK3β-mediated mPTP opening may be involved in I/R injury and regulated by mitoHK-II binding and activity.Entities:
Keywords: Glycogen synthase kinase-3β; Ischemia–reperfusion; Mitochondrial hexokinase II; Mitochondrial permeability transition pore
Mesh:
Substances:
Year: 2018 PMID: 29671257 DOI: 10.1007/s12576-018-0611-y
Source DB: PubMed Journal: J Physiol Sci ISSN: 1880-6546 Impact factor: 2.781